Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Pharmaceutical Packaging and Labeling Services

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract involves secondary packaging, labeling, and the application of barcodes on Hydralazine HCL tablets. The barcodes specified are ladder-oriented GS1-128 or HIBCC types, and the labeling includes human-readable text to ensure clear identification and compliance with industry standards. The services covered are aimed at enhancing product traceability and regulatory adherence through accurate packaging and labeling processes. Issued by Nac Pharmaceuticals under the Department of Veterans Affairs, the contract falls within the NAICS code 325991, which pertains to pharmaceutical manufacturing and related services. While some specifics such as location and point of contact are not provided, the subcontract focuses explicitly on pharmaceutical packaging and labeling practices to support distribution and inventory management within the healthcare supply chain.

General Info

Secondary packaging, labeling, and barcode application for Hydralazine HCL tablets by Nac Pharmaceuticals.

NAICS

325991 - Custom Compounding of Purchased Resins

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36e79725R0060.

The full solicitation package (4 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Hydralazine HCL Tablets Effective 04/08/2026 to 04/07/2027

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Secondary packaging, labeling, and barcode application for Hydralazine HCL tablets with ladder-oriented GS1-128 or HIBCC barcodes and human-readable text.

Similar Contracts

Same NAICS industry code

NAICS: 325991
New
DIBBS
NONMETALLIC SPECIAL
Solicitation # SPE8E9-27-T-0247
Solicitation SPE8E9-27-T-0247 is a fixed-price procurement issued by the Department of Defense, specifically DLA Troop Support, Construction and Equipment MRO SVC I, for 142 feet of a nonmetallic special shaped rubber section. The item, identified by NSN 9390-00-554-9674, is classified as a commercial item and must adhere to technical standards BAC1521-413, superseded by ASTM D 2000 M 3 BE 610 A14 E014 F19 Z3Z3. The rubber must be white, conforming to Federal Standard 595 Standard 33711, and must comply with engineering data drawing 20041548, specifically notes 1, 3, and 12. Delivery is required at the DLA Distribution Depot Oklahoma at Tinker AFB, with a need ship date of May 19, 2026, and a final delivery date of December 29, 2026. The contract imposes strict compliance requirements, including CMMC Level 2 certification and adherence to export controls under ITAR and EAR, requiring an approved US/Canada Joint Certification Program certification for access to technical data. Packaging and marking must follow MIL-STD-2073-1E and MIL-STD-129, with specific palletization requirements per RP001. Invoicing is to be processed electronically through the Wide Area WorkFlow system. The government will not evaluate offers utilizing additive manufacturing. Additionally, the procurement incorporates various FAR and DFARS clauses regarding the Buy American Act, the Berry Amendment, and prohibitions on hexavalent chromium and communist Chinese military companies. Inspection and acceptance will occur at the destination.
CONSTRUCTION & EQUIPMENT MRO SVC I

POSTED

3 days ago

DEADLINE

in 8 days
View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 12 days
View Details
NAICS: 325412
New
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Pharmaceutical Preparation Manufacturing

POSTED

6 days ago

DEADLINE

in 8 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS